ESB 2009

Welcome and facts and figures
Images / Impressions of ESB2009
Programme
Contact

Welcome and facts and figures

The Swiss Society for Biomaterials (SSB) are proud to have hosted the 22nd European Conference on Biomaterials (ESB2009), from September 7-11, 2009 in the Beaulieu Convention Centre, Lausanne. The conference was the annual conference of the European Society for Biomaterials (ESB). ESB2009 strengthened the scientific basis of the traditional ESB core topics with several changes to the normal ESB conference structure as well as increasing interaction with both the clinical and industrial side of biomaterials. The majority of participants came from Europe but also a considerable number from Asia, USA and overseas composed of researchers, medical professionals and manufacturers. ESB2009 attracted clinicians by holding several keynote lectures from clinicians, by subdividing the meeting in day themes.

  • 1044 abstracts were submitted for presentation at ESB2009
    (The most submitted to an ESB event - previous record 750 abstracts)
    There were 250 oral presentations and over 750 posters.
  • 1201 attendees participated at ESB2009 (see list below)
    (The highest registration number - - previous record 1100, ESB2005, Sorrento Italy)

New areas from ESB2009

  • CME Accreditation - 27 European external CME credits for clinicians
  • SGO Accreditation - (Schw. Gesellschaft für Orthopädische Chirurgie), 25 credits.
  • Theme of the Day session, running throughout the day
  • Single session clinical plenary followed by state of the art in research plenary.
  • Conflict of interest statements
  • Plenary lectures at both the opening and closing ceremonies.
  • Brought EORS as new sister society to ESB
  • Restrengthened connections to current ESB sister societies.
  • Exhibitor evening to connect the scientists to the industry.

ESB2009 drew on the extensive MedTech industry within Switzerland and Europe to bring closer working relationships with industry. We collaborated with alliance, whose function is to connect the French Swiss universities to local industries including MedTech ones. Alliance is also part of the European Enterprise Network whose goal is to help support and build up international technology partnerships within Europe, especially for small businesses. ESB2009 also our organized an exhibitor evening. Partnering Event. ESB2009 started each day with the ESB award lectures (Jean Leray and George Winter). This was followed with a new idea at ESB. Remaining as a single session there was a lecture on clinical problems that need to be solved within a theme of the day and a lecture of the state of the art in research of that area. Subsequently, we moved onto the breakout parallel sessions. One of the five parallel sessions continued the "theme of the day", throughout the day. Pre-meeting and during meeting workshops, which were mainly educational were also held. Another new idea to improve the opening and closing was the addition of plenary lectures at these events. Both the opening ceremony on the evening of the 7th had a plenary lecture from Prof. Jeffrey A. Hubbell and the closing ceremony on the evening of the 11th had the award lecture from Prof Buddy Ratner (where 300 attendees remained). ESB2009 succeeded to connect biomaterial research with current clinical problems to produce progressive translational research and was the venue to present and discuss basic, applied/translational & clinical research in a multi disciplinary environment. ESB2009 also introduced conflict of interest statements (Compulsory Presentation Statements) to let ESB 2009 participants better interpret posters and talks declaring any potential conflict of interest that he/she or any co-author of the study might have with the presented data. This will need more enforcement for future meetings, as this was a partial success.

Accreditation. The AO Foundation is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net The "22nd European Conference on Biomaterials, Lausanne, Switzerland" is designated for a maximum of 27 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. EACCME credits are recognised by the American Medical Association towards the Physician's recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, contact the AMA. Conference accrediitation certificate (PDF 43KB). ESB2009 also received 25 points for the congress from SGO (Schw. Gesellschaft für Orthopädische Chirurgie).

Thank you for attending and participating to make ESB2009 a very successful and rewarding meeting.

Yours Sincerely,

Prof R.Geoff Richards, Prof Marc Bohner and PD Dr. Christine Wandrey

Congress Organisers on behalf of the Swiss Society for Biomaterials.

Attendee Location

Country Number Percentage
Austria 12 1.07
Australia 19 1.69
Belgium 15 1.33
Brazil 21 1.87
Banbladesh 1 0.09
Canada 3 0.27
China 10 0.89
Columbia 1 0.09
Czech Republic 15 1.33
Germany 107 9.52
Denmark 6 0.53
Estonia 1 0.09
Finland 12 1.07
France 73 6.49
Greece 10 0.89
Hong Kong 2 0.18
Ireland 28 2.49
Israel 2 0.18
India 15 1.33
Iraq 1 0.09
Iran 7 0.62
Italy 77 6.85
Japan 66 5.87
Korea 26 2.31
Mexico 1 0.09
Malaysia 4 0.36
Moldowia 1 0.09
Netherlands 37 3.29
Norway 5 0.44
Poland 20 1.78
Portugal 25 2.22
Romania 25 2.22
Russia 3 0.27
Sweden 27 2.40
Singapore 6 0.53
Slovakia 2 0.18
Spain 79 7.03
Switzerland 278 24.73
Thailand 1 0.09
Turkey 4 0.36
Taiwan 6 0.53
UK 115 10.23
USA 32 2.85
Total 1201 106.85



Programme

ESB2009- Full Programme (oral & posters)
Overview

ESB2009 Bridging Public and Private Research on Biomaterials
Industrial Day & Partnering Event from Alps Bio Cluster
(PDF 151Kb, updated 22072009)
Sept 8, 2009 Beaulieu, Lausanne, Switzerland

Workshop Programmes
CCMX
Invibio

Contact

All transactions as related to the event (e.g. sponsorship / exhibition) go through ConCoord.
Please fax, mail, or email questions to:

ESB 2009 Office,
Karin Fahnemann-Nolte
ConCoord GmbH. Riedeggstrasse 8
CH-3626 Hünibach, Switzerland

Email: ConCoord at hispeed.ch
Phone +41 33 223 17 34
Fax +41 33 534 45 27
http://www.concoord.ch

For Scientific questions contact:

ESB2009 Swiss National Scientific Committee Chair
PD Dr.habil. Christine Wandrey, MER
Ecole Polytechnique Fédérale de Lausanne (EPFL)
Laboratoire de Médecine Régénérative et de Pharmacobiologie (LMRP)
http://people.epfl.ch/christine.wandrey